These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 1970200

  • 1. Antilymphocytic antibodies and bone marrow transplantation. XI. Evidence that reduced Thy-1 expression in Thy-1.1 mice prevents suppression of graft-versus-host disease with anti-Thy-1 monoclonal antibodies.
    Mysliwietz J, Thierfelder S, Hoffmann-Fezer G, Kummer U.
    Transplantation; 1990 Apr; 49(4):749-55. PubMed ID: 1970200
    [Abstract] [Full Text] [Related]

  • 2. Antigen density on target cells determines the immunosuppressive potential of rat IgG2b monoclonal antibodies.
    Kummer U, Thierfelder S, Mysliwietz J.
    Eur J Immunol; 1990 Jan; 20(1):107-12. PubMed ID: 1968387
    [Abstract] [Full Text] [Related]

  • 3. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement.
    Thierfelder S, Cobbold S, Kummer U, Waldmann H, Schuh R.
    Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prevention of lethal graft-versus-host disease in mice by monoclonal antibodies directed against T cells or their subsets. I. Evidence for the induction of a state of tolerance based on suppression.
    Knulst AC, Tibbe GJ, Noort WA, Bril-Bazuin C, Benner R, Savelkoul HF.
    Bone Marrow Transplant; 1994 Mar; 13(3):293-301. PubMed ID: 8199571
    [Abstract] [Full Text] [Related]

  • 6. Amelioration of acute graft-versus-host disease and re-establishment of tolerance by short-term treatment with an anti-TCR antibody.
    Maeda T, Eto M, Lin T, Nishimura Y, Kong YY, Nomoto K, Nomoto K.
    J Immunol; 1994 Nov 01; 153(9):4311-20. PubMed ID: 7930630
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative effects of various T cell subtypes on GVHD in a murine model for MHC-matched unrelated donor transplant.
    OKunewick JP, Kociban DL, Buffo MJ.
    Bone Marrow Transplant; 1990 Mar 01; 5(3):145-52. PubMed ID: 1691938
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Proliferative capacity of senescent lymphocytes. II. Monoclonal antibody stimulation of mucosal and systemic lymphocytes via T cell activation molecules, CD3 epsilon, T cell receptor V beta 8 chain, and phosphatidylinositol-linked anchored receptors THY-1 and LY-6A.2/TAP.
    Green-Johnson JM, Szewczuk MR.
    Reg Immunol; 1990 Mar 01; 3(6):323-35. PubMed ID: 1983438
    [Abstract] [Full Text] [Related]

  • 13. Anti-IL-4 antibody prevents graft-versus-host disease in mice after bone marrow transplantation. The IgE allotype is an important marker of graft-versus-host disease.
    Ushiyama C, Hirano T, Miyajima H, Okumura K, Ovary Z, Hashimoto H.
    J Immunol; 1995 Mar 15; 154(6):2687-96. PubMed ID: 7876541
    [Abstract] [Full Text] [Related]

  • 14. Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences.
    Korngold R, Sprent J.
    J Immunol; 1985 Nov 15; 135(5):3004-10. PubMed ID: 3876371
    [Abstract] [Full Text] [Related]

  • 15. CD4-/CD8-T cells: amplification in spleens of mice following in vivo treatment with monoclonal antibody anti-L3T4.
    Ermak TH, Steger HJ.
    Eur J Immunol; 1988 Feb 15; 18(2):231-5. PubMed ID: 2894995
    [Abstract] [Full Text] [Related]

  • 16. Nonmitogenic anti-CD3F(ab')2 fragments inhibit lethal murine graft-versus-host disease induced across the major histocompatibility barrier.
    Blazar BR, Taylor PA, Snover DC, Bluestone JA, Vallera DA.
    J Immunol; 1993 Jan 01; 150(1):265-77. PubMed ID: 8417127
    [Abstract] [Full Text] [Related]

  • 17. Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.
    Drobyski WR, Majewski D, Ozker K, Hanson G.
    J Immunol; 1998 Sep 01; 161(5):2610-9. PubMed ID: 9725263
    [Abstract] [Full Text] [Related]

  • 18. Stimulation of murine T cells via the Ly-6C antigen: lack of proliferative response in aberrant T cells from lpr/lpr and gld/gld mice despite high Ly-6C antigen expression.
    Dumont FJ.
    J Immunol; 1987 Jun 15; 138(12):4106-13. PubMed ID: 2438334
    [Abstract] [Full Text] [Related]

  • 19. Antilymphocytic antibodies and marrow transplantation. VI. Absence of immunosuppression in vivo after injection of monoclonal antibodies blocking graft-versus-host reactions and humoral antibody formation in vitro.
    Thierfelder S, Hoffmann-Fezer G, Rodt H, Doxiadis I, Eulitz M, Kummer U.
    Transplantation; 1983 Mar 15; 35(3):249-54. PubMed ID: 6340277
    [Abstract] [Full Text] [Related]

  • 20. In vivo immunosuppression by pan-T cell antibodies relates to their isotype and to their C1q uptake.
    Kummer U, Thierfelder S, Hoffmann-Fezer G, Schuh R.
    J Immunol; 1987 Jun 15; 138(12):4069-74. PubMed ID: 2884259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.